REQUEST A DEMO
Total
USD $0.00
Search more companies

Med Research, S. R. O. (Slovakia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Med Research, S. R. O. Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Med Research, S. R. O. is a company in Slovakia, with a head office in Bratislava. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. Med Research, S. R. O. was incorporated on December 14, 2012. 2 - 3 (2019) employees currently work for Med Research, S. R. O.. In 2023, the company reported a net sales revenue increase of 7.12%. Over the same period, its total assets grew by 19.63%. The net profit margin of Med Research, S. R. O. decreased by 1.03% in 2023.

Headquarters
29. augusta, 28/C
Bratislava; Bratislavsky; Postal Code: 81109

Contact Details: Purchase the Med Research, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Med Research, S. R. O. report to view the information.
Outstanding Shares:
Purchase the Med Research, S. R. O. report to view the information.
Registered Capital:
Purchase the Med Research, S. R. O. report to view the information.
Incorporation Date:
December 14, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Med Research, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
7.12%
Total operating revenue
6.79%
Operating profit (EBIT)
-31.42%
Net Profit (Loss) for the Period
-29.08%
Total assets
19.63%
Total equity
-22.99%
Operating Profit Margin (ROS)
-1.28%
Net Profit Margin
-1.03%
Return on Equity (ROE)
-6.25%
Debt to Equity Ratio
0.12%
Quick Ratio
-0.15%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?